127 related articles for article (PubMed ID: 36519431)
1. Difference in the Inhibitory Effect of Thiol Compounds and Demetallation Rates from the Zn(II) Active Site of Metallo-β-lactamases (IMP-1 and IMP-6) Associated with a Single Amino Acid Substitution.
Yamaguchi Y; Kato K; Ichimaru Y; Uenosono Y; Tawara S; Ito R; Matsuse N; Wachino JI; Toma-Fukai S; Jin W; Arakawa Y; Otsuka M; Fujita M; Fukuishi N; Sugiura K; Imai M; Kurosaki H
ACS Infect Dis; 2023 Jan; 9(1):65-78. PubMed ID: 36519431
[TBL] [Abstract][Full Text] [Related]
2. Mutagenesis of zinc ligand residue Cys221 reveals plasticity in the IMP-1 metallo-β-lactamase active site.
Horton LB; Shanker S; Mikulski R; Brown NG; Phillips KJ; Lykissa E; Venkataram Prasad BV; Palzkill T
Antimicrob Agents Chemother; 2012 Nov; 56(11):5667-77. PubMed ID: 22908171
[TBL] [Abstract][Full Text] [Related]
3. Structural insights into the substrate specificity of IMP-6 and IMP-1 metallo-β-lactamases.
Yamamoto K; Tanaka H; Kurisu G; Nakano R; Yano H; Sakai H
J Biochem; 2022 Dec; 173(1):21-30. PubMed ID: 36174533
[TBL] [Abstract][Full Text] [Related]
4. Elucidating the Role of Residue 67 in IMP-Type Metallo-β-Lactamase Evolution.
LaCuran AE; Pegg KM; Liu EM; Bethel CR; Ai N; Welsh WJ; Bonomo RA; Oelschlaeger P
Antimicrob Agents Chemother; 2015 Dec; 59(12):7299-307. PubMed ID: 26369960
[TBL] [Abstract][Full Text] [Related]
5. Understanding the determinants of substrate specificity in IMP family metallo-β-lactamases: the importance of residue 262.
Pegg KM; Liu EM; George AC; LaCuran AE; Bethel CR; Bonomo RA; Oelschlaeger P
Protein Sci; 2014 Oct; 23(10):1451-60. PubMed ID: 25131397
[TBL] [Abstract][Full Text] [Related]
6. Computational modelling of potential Zn-sensitive non-β-lactam inhibitors of imipenemase-1 (IMP-1).
Ayipo YO; Ahmad I; Alananzeh W; Lawal A; Patel H; Mordi MN
J Biomol Struct Dyn; 2023 Nov; 41(19):10096-10116. PubMed ID: 36476097
[TBL] [Abstract][Full Text] [Related]
7. Insight into stereochemistry of a new IMP allelic variant (IMP-55) metallo-β-lactamase identified in a clinical strain of Acinetobacter baumannii.
Shakibaie MR; Azizi O; Shahcheraghi F
Infect Genet Evol; 2017 Jul; 51():118-126. PubMed ID: 28336429
[TBL] [Abstract][Full Text] [Related]
8. Crystal structure of IMP-2 metallo-β-lactamase from Acinetobacter spp.: comparison of active-site loop structures between IMP-1 and IMP-2.
Yamaguchi Y; Matsueda S; Matsunaga K; Takashio N; Toma-Fukai S; Yamagata Y; Shibata N; Wachino J; Shibayama K; Arakawa Y; Kurosaki H
Biol Pharm Bull; 2015; 38(1):96-101. PubMed ID: 25744464
[TBL] [Abstract][Full Text] [Related]
9. [Structure-Function Analysis and Development of Inhibitors of Metallo-β-lactamases Conferring Drug Resistance in Bacteria].
Yamaguchi Y
Yakugaku Zasshi; 2015; 135(11):1299-305. PubMed ID: 26521879
[TBL] [Abstract][Full Text] [Related]
10. Probing the Interaction of Aspergillomarasmine A with Metallo-β-lactamases NDM-1, VIM-2, and IMP-7.
Bergstrom A; Katko A; Adkins Z; Hill J; Cheng Z; Burnett M; Yang H; Aitha M; Mehaffey MR; Brodbelt JS; Tehrani KHME; Martin NI; Bonomo RA; Page RC; Tierney DL; Fast W; Wright GD; Crowder MW
ACS Infect Dis; 2018 Feb; 4(2):135-145. PubMed ID: 29091730
[TBL] [Abstract][Full Text] [Related]
11. The directed evolution of NDM-1.
Thomas CA; Cheng Z; Bethel CR; Hujer AM; Sturgill AM; Onuoha K; Page RC; Bonomo RA; Crowder MW
Antimicrob Agents Chemother; 2023 Nov; 67(11):e0071423. PubMed ID: 37874296
[TBL] [Abstract][Full Text] [Related]
12. Sulfamoyl Heteroarylcarboxylic Acids as Promising Metallo-β-Lactamase Inhibitors for Controlling Bacterial Carbapenem Resistance.
Wachino JI; Jin W; Kimura K; Kurosaki H; Sato A; Arakawa Y
mBio; 2020 Mar; 11(2):. PubMed ID: 32184250
[TBL] [Abstract][Full Text] [Related]
13. A multiscale approach to predict the binding mode of metallo beta-lactamase inhibitors.
Gervasoni S; Spencer J; Hinchliffe P; Pedretti A; Vairoletti F; Mahler G; Mulholland AJ
Proteins; 2022 Feb; 90(2):372-384. PubMed ID: 34455628
[TBL] [Abstract][Full Text] [Related]
14. Crystal structures of VIM-1 complexes explain active site heterogeneity in VIM-class metallo-β-lactamases.
Salimraj R; Hinchliffe P; Kosmopoulou M; Tyrrell JM; Brem J; van Berkel SS; Verma A; Owens RJ; McDonough MA; Walsh TR; Schofield CJ; Spencer J
FEBS J; 2019 Jan; 286(1):169-183. PubMed ID: 30430727
[TBL] [Abstract][Full Text] [Related]
15. Structure and Molecular Recognition Mechanism of IMP-13 Metallo-β-Lactamase.
Softley CA; Zak KM; Bostock MJ; Fino R; Zhou RX; Kolonko M; Mejdi-Nitiu R; Meyer H; Sattler M; Popowicz GM
Antimicrob Agents Chemother; 2020 May; 64(6):. PubMed ID: 32205343
[TBL] [Abstract][Full Text] [Related]
16. Metallo-β-Lactamase Inhibitors Inspired on Snapshots from the Catalytic Mechanism.
Palacios AR; Rossi MA; Mahler GS; Vila AJ
Biomolecules; 2020 Jun; 10(6):. PubMed ID: 32503337
[TBL] [Abstract][Full Text] [Related]
17. Plasmid-encoded metallo-beta-lactamase (IMP-6) conferring resistance to carbapenems, especially meropenem.
Yano H; Kuga A; Okamoto R; Kitasato H; Kobayashi T; Inoue M
Antimicrob Agents Chemother; 2001 May; 45(5):1343-8. PubMed ID: 11302793
[TBL] [Abstract][Full Text] [Related]
18. β-Lactamases and β-Lactamase Inhibitors in the 21st Century.
Tooke CL; Hinchliffe P; Bragginton EC; Colenso CK; Hirvonen VHA; Takebayashi Y; Spencer J
J Mol Biol; 2019 Aug; 431(18):3472-3500. PubMed ID: 30959050
[TBL] [Abstract][Full Text] [Related]
19. 4-Amino-1,2,4-triazole-3-thione-derived Schiff bases as metallo-β-lactamase inhibitors.
Gavara L; Sevaille L; De Luca F; Mercuri P; Bebrone C; Feller G; Legru A; Cerboni G; Tanfoni S; Baud D; Cutolo G; Bestgen B; Chelini G; Verdirosa F; Sannio F; Pozzi C; Benvenuti M; Kwapien K; Fischer M; Becker K; Frère JM; Mangani S; Gresh N; Berthomieu D; Galleni M; Docquier JD; Hernandez JF
Eur J Med Chem; 2020 Dec; 208():112720. PubMed ID: 32937203
[TBL] [Abstract][Full Text] [Related]
20. Structural insights into the subclass B3 metallo-β-lactamase SMB-1 and the mode of inhibition by the common metallo-β-lactamase inhibitor mercaptoacetate.
Wachino J; Yamaguchi Y; Mori S; Kurosaki H; Arakawa Y; Shibayama K
Antimicrob Agents Chemother; 2013 Jan; 57(1):101-9. PubMed ID: 23070156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
